DRAGON ROUGE – Trademark Portfolio
Entity Type: 99
DRAGON ROUGE holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 5 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include DRAGON ROUGE. The owner is based in Suresnes Cedex 92153.
32, rue Pagès BP 83
Suresnes Cedex 92153 , FR
Showing of trademarks Trademarks
Trademark Classifications
DRAGON ROUGE's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does DRAGON ROUGE have?
DRAGON ROUGE has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does DRAGON ROUGE file in?
DRAGON ROUGE files trademarks across 5 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 16 (Paper Goods), Class 38 (Telecommunications). Class 35 covers advertising; business management; business administration; office functions.
What are DRAGON ROUGE's most well-known trademarks?
DRAGON ROUGE's registered trademark portfolio includes well-known marks such as DRAGON ROUGE. These are among 1 currently registered trademark in the portfolio.
What is DRAGON ROUGE's trademark registration success rate?
DRAGON ROUGE has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.